A medication used for treating leukemia is showing promise in reducing the effects of Alzheimer's disease.<br />According to a small clinical study, Nilotinib is safe and has few side effects when used at low doses.<br />Nearly 6 million Americans suffer from Alzheimer's disease, which is a form of dementia.<br />While no cure exists, drug therapy may slow disease progression in some people.<br />According to UPI, Nilotinib was approved by the U.S. Food and Drug Administration in 2007 to treat chronic myeloid leukemia.
